THE NICKLES GROUP, LLC

Lobbying for OMEROS CORPORATION · Biopharmaceutical company.

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 18, 2025

Income

$40,000.00

What the client paid this registrant for the period.

Client based in

Washington

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Medicare/Medicaid

Monitored separate payment policy for nonopioid alternatives. Issues involving rare disease therapies.

Health Issues

Issues related to rare pediatric disease and Priority Review Vouchers (PRVs).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.